# Holly Rockweiler

> Holly Rockweiler is a biomedical engineer, co-founder and CEO of Portland-based Madorra, and an OHSU Innovates entrepreneur-in-residence. After beginning her career in cardiovascular-device research at Boston Scientific, she entered Stanford's Biodesign Innovation Fellowship and co-founded Madorra in 2014 with Ryan Krone. Her work combines needs-driven product design, patient interviews, clinical research, fundraising and regulatory strategy; Madorra received FDA Breakthrough Device designation in 2021 and enrolled the first participant in its pivotal WAVES study in March 2026.

- **Role:** Co-Founder and CEO at Madorra Inc.; Entrepreneur-in-Residence at OHSU Innovates
- **Organizations:** Madorra Inc., OHSU Innovates, Stanford Biodesign, Boston Scientific, CEOX, Ferolyn Fellowship
- **Education:** BS in Biomedical Engineering, Washington University in St. Louis, MS in Biomedical Engineering, Washington University in St. Louis, Biodesign Innovation Fellowship, Stanford University
- **Known for:** Co-founded Madorra out of the Stanford Biodesign Innovation Fellowship., Contributed to more than 20 pending and issued patents according to a 2024 interview biography; an NCI profile previously credited her with 15-plus medical-field patents., Led Madorra to FDA Breakthrough Device designation in 2021.

## Career timeline

- **2007** — Graduated magna cum laude from Washington University in St. Louis with a BS in biomedical engineering; also earned an MS in the field.
- **2007-2013** — Worked at Boston Scientific, ultimately as a senior research scientist developing cardiovascular-device therapies and conducting preclinical and clinical research.
- **2013-2014** — Completed the Stanford Biodesign Innovation Fellowship, where she worked with Ryan Krone and used ethnographic research to identify unmet clinical needs.
- **2014** — Co-founded Madorra and became its CEO.
- **2016** — Moved Madorra from the Bay Area to Portland; the company won the audience favorite vote at the Oregon Bio Company Pitch Showcase.
- **2017** — Madorra won PitchFestNW and the OEN Angel Oregon Showcase, including a $200,000 investment and a $15,000 cash award.
- **2018** — Closed the first tranche of a Series A led by OneVentures.
- **2019** — Named to a Top 100 Women in FemTech and HealthTech list.
- **2021** — Madorra received FDA Breakthrough Device designation; Rockweiler graduated from the fifth Ferolyn Fellowship cohort.
- **2022** — Named UCSF Rosenman Institute Health Tech Leader of the Month for February.
- **2024** — Madorra received a Direct-to-Phase II NIH/NICHD SBIR award; Rockweiler spoke on the Women Innovating Women's Healthcare panel at Washington University.
- **2025** — Served as an entrepreneur-in-residence with OHSU Innovates.
- **2026** — Madorra enrolled the first participant in its pivotal WAVES study; Rockweiler was listed as a presenter at the Oregon Innovation Showcase.

## Achievements

- Co-founded Madorra out of the Stanford Biodesign Innovation Fellowship.
- Contributed to more than 20 pending and issued patents according to a 2024 interview biography; an NCI profile previously credited her with 15-plus medical-field patents.
- Led Madorra to FDA Breakthrough Device designation in 2021.
- Won PitchFestNW in 2017 from a field of 74 presenting startups.
- Led Madorra to the 2017 OEN Angel Oregon Showcase first prize, including a $200,000 investment and $15,000 cash award.
- Received Boston Scientific Technology Assessment Grant Awards in 2011 for two consecutive years.
- Received the 2008 Lupina Young Researchers Award for work in health-system dynamics.
- Named UCSF Rosenman Institute Health Tech Leader of the Month in February 2022.
- Graduated from the Ferolyn Fellowship in 2021.
- Serves as an entrepreneur-in-residence at OHSU Innovates.

## Latest updates

- **2026-05** — Scheduled as a panelist for Portland Startup Week's Building Here: Healthcare Innovation and Oregon's Next Chapter event.
- **2026-03** — Announced that Madorra had enrolled the first participant in its pivotal WAVES study.
- **2026** — Listed as an Up and Coming presenter at the Oregon Innovation Showcase.
- **2025** — Participated in OHSU Innovates programming as an entrepreneur-in-residence.
- **2024-04** — Joined the Women Innovating Women's Healthcare panel at Washington University in St. Louis.

## Links

- Website: https://madorra.com
- LinkedIn: https://www.linkedin.com/in/hollyrockweiler
- Twitter/X: https://twitter.com/MadorraMedical
- Facebook: https://www.facebook.com/MadorraMedical

---

Profile page: https://yespress.io/holly-rockweiler
Published by YesPress — https://yespress.io
Last updated: 2026-08-26